{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "ANTENATAL SCREENING FOR DOWNS,EDWARDS AND PATAUS SYNDROME"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "08058"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "5.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Midwives, obstetricians, radiography"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "21 October 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "20 October 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Downs, Edwards, Pataus, NIPT, antenatal screening"
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "NHS Fetal Anomaly Screening Programme ( FASP)"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Division 7"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Emma Neate"
                    },
                    {
                        "text": "Antenatal and Newborn Screening Co-ordinator"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2610 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2612 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "MSE Maternity and Gynaecology Policy Working Group"
                    },
                    {
                        "text": "01 October 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Miss Rao"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "17 September 2021"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "19 October 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "November 2021"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Vidya Thakur"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "22 September 2021"
                    },
                    {
                        "text": "Dr Hassan"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "22 September 2021"
                    },
                    {
                        "text": "Lavina D'Souza"
                    },
                    {
                        "text": "Lead Midwife for Antenatal Clinic"
                    },
                    {
                        "text": "22 September 2021"
                    },
                    {
                        "text": "Chris Berner"
                    },
                    {
                        "text": "Lead Midwife for Clinical Governance"
                    },
                    {
                        "text": "22 September 2021"
                    },
                    {
                        "text": "Sharon Murrell"
                    },
                    {
                        "text": "Head of Midwifery"
                    },
                    {
                        "text": "22 September 2021"
                    },
                    {
                        "text": "Diane Whybro"
                    },
                    {
                        "text": "Antenatal Clinic Midwife"
                    },
                    {
                        "text": "22 September 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Committee if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "MSE Maternity and Gynaecology Policy Working Group"
                    },
                    {
                        "text": "01 October 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) MSEPO-21017 Infection control standard precautions MSEPO-20215 Hand hygiene 04272 Maternity care guideline 08045 Amniocentesis for antenatal diagnosis 08046 Interpret and Act on CVS and amniocentesis results 06036 Maternity Record Keeping 06031 Receiving and acting on test results in maternity by both hospital and community 09127A Interpreting and translation policy 09113 Calling paediatric staff and for obtaining paediatric referral"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 13,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Nicola Leslie"
                    },
                    {
                        "text": "Created"
                    },
                    {
                        "text": "August 2008"
                    },
                    {
                        "text": "1.1"
                    },
                    {
                        "text": "Kathleen Bird"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "November 2009"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Nicola Leslie"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "February 2012"
                    },
                    {
                        "text": "2.1"
                    },
                    {
                        "text": "Nicola Leslie"
                    },
                    {
                        "text": "Clarification to point14.0"
                    },
                    {
                        "text": "September 2012"
                    },
                    {
                        "text": "2.2"
                    },
                    {
                        "text": "Sarah Moon"
                    },
                    {
                        "text": "Clarification to point14.0"
                    },
                    {
                        "text": "February 2013"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Nicola Leslie"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "March 2015"
                    },
                    {
                        "text": "3.1"
                    },
                    {
                        "text": "Nicola Leslie"
                    },
                    {
                        "text": "Clarification to point 4.0, 5.0, 8.0, 9.0 18.0"
                    },
                    {
                        "text": "04 July 2016"
                    },
                    {
                        "text": "4.0"
                    },
                    {
                        "text": "Emma Neate"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "16 July 2018"
                    },
                    {
                        "text": "4.1"
                    },
                    {
                        "text": "Emma Neate Rachel Smith"
                    },
                    {
                        "text": "Clarification to point 2.1,7.3,19.0 & 20.0 Addition of new point 15.0 and 16.0 and Appendix D and subsequent renumbering and updating format"
                    },
                    {
                        "text": "02 July 2020"
                    },
                    {
                        "text": "4.2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "5 month extension granted by Sarah Moon due to MSE standardisation"
                    },
                    {
                        "text": "24 May 2021"
                    },
                    {
                        "text": "5.0"
                    },
                    {
                        "text": "Emma Neate"
                    },
                    {
                        "text": "Clarification to points 3.1, 4.3, 5.0, 7.4 Change \u201cRisk\u201d to \u201cChance\u201d removal of 14.7, removal of Appendix C, and subsequent renumbering and updating"
                    },
                    {
                        "text": "21 October 2021"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "text": "Contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction ............................................................................................................... 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Scope.......................................................................................................................... 4  Definitions .................................................................................................................. 4  Roles and Responsibilites within the Trust ............................................................ 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Aetiology ................................................................................................................... 5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Incidence .................................................................................................................... 5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Aims............................................................................................................................ 6"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Objectives .................................................................................................................. 6  Informed Consent for Downs, Edwards and Pataus Screening\u2026\u2026\u2026\u2026\u2026\u2026.......7  Downs, Edwards and Pataus Screening\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026....\u2026\u2026.7  First Trimester Screening\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026......\u2026..8  Second Trimester Screening\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026......\u2026..8  Results\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026....9 Low Chance Results\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026.9 High Chance Results\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...10  Failsafe Checks \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026.11  Reporting Incidents within the Screening Programme........................................11  Record Keeping\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026.\u202611  Training Requirements\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026....12  Infection Prevention\u2026\u2026\u2026\u2026\u2026\u2026...\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026..12  Audit and Monitoring\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026.\u202612  Approval and Implementation\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.13  Equality Impact Assessment\u2026\u2026\u2026.\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...13  References\u2026\u2026\u2026\u2026...\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026..\u2026.14 Appendix A: Down's Endwards' and Patau's Screening form\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026...15 Appendix B: Neonatal Alert Form \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u202617 Appendix C: Antenatal and Newborn Screening st Trimester Screening SOP\u2026\u2026.\u2026\u2026..18"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "To offer first trimester screening for Downs, Edwards and Pataus syndrome to all patients registered with the trust (booked) before  weeks of pregnancy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "prefix": 20.0,
                "text": "To offer second trimester serum screening to patients who present at ultrasound on or after  weeks, but before  weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The method of screening is first trimester screening, combining maternal age, biochemistry and ultrasound measurement of fetal nuchal translucency to provide a pregnant woman with a chance of having a baby with Down's or Edwards'/Patau's syndromes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            }
        },
        {
            "type": "table",
            "sequence_num": 21,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Term"
                    },
                    {
                        "text": "Definition"
                    },
                    {
                        "text": "T21"
                    },
                    {
                        "text": "Down's Syndrome"
                    },
                    {
                        "text": "T18"
                    },
                    {
                        "text": "Edward's syndrome"
                    },
                    {
                        "text": "T13"
                    },
                    {
                        "text": "Patau syndrome"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and responsibilities within the Trust"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "All policies, procedures and guidelines will be approved by the Obstetrics & Gynaecology Guideline Steering Groups, which are the specialist groups with the authority to approve local documents. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "The Clinical Director in partnership with the Head of Midwifery is responsible for the Implementation of this policy within the MSE Maternity services."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "The Director of Midwifery, Heads of Midwifery and Gynaecology, Maternity matrons and managers are responsible for ensuring all relevant staff are aware of the policy and that it is implemented."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "The Clinical Lead Consultant, Maternity Matrons and Managers are responsible for ensuring the implementation of this policy within the clinical setting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "All maternity staff are responsible for ensuring they are familiar with this policy in relation to their practice and have the appropriate skills to implement this."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Aetiology"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Inside the cells of our bodies there are tiny structures called chromosomes. These chromosomes carry the genes that determine how we develop. There are 23 pairs of chromosomes in each cell. Problems can occur when the sperm or egg cells are produced which can lead to a baby having an extra chromosome."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 1,
                "prefix": 5.2,
                "text": "Down's syndrome:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "prefix": 21.0,
                "text": "5.2.1 People with Down's syndrome (T21) have extra chromosome  in the cells of their body. A baby born with T21 will have a learning disability. They may have communication problems and difficulty managing some everyday tasks. It is impossible to know what level of learning disability a baby with T21 will have. It can vary from mild to severe."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 1,
                "text": "5.2.2 Some health problems are more common in people with T21, for example, heart conditions, and problems with the digestive system, hearing and vision. Some problems can be serious but many can be treated. People with Down's syndrome have distinctive facial features including almond shaped eyes. Like all children, they also inherit features from their parent. T21 affects 1 in every 1000 births."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 1,
                "prefix": 5.3,
                "text": "Edward's and Patau's:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "text": "5.3.1 Sadly, most babies with Edward's or Patau's will die before they are born, be stillborn or die shortly after birth. Some babies may survive to adulthood but this is rare."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "5.3.2 In Edwards' syndrome (T18) there is an extra copy of chromosome  in each cell. All babies born with T18 will have a wide range of problems, which are usually extremely serious \u2013 these may include major brain abnormalities. Babies affected by T18 can have heart problems, unusual head and facial features, growth problems and be unable to stand or walk. T18 affects about 3 of every 10,000 births."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "5.3.3 In Patau's syndrome (T13) there is an extra copy of chromosome  in each cell. All babies born with T13 will have a wide range of problems, which are usually extremely serious \u2013 these may include major brain abnormalities. Babies affected by T13 can have heart problems, a cleft lip and palate, growth problems, poorly formed eyes and ears, problems with their kidneys and are unable to stand or walk. T13 affects about 2 of every 10,000 births."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Incidence"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 1,
                "prefix": 6.1,
                "text": "The early pregnancy scan 11-14 weeks The scan has several purposes. It is to:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "text": "Confirm viability"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": "Ascertain if it is a singleton or multiple pregnancy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "text": "Estimate gestational age"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "text": "Detect major structural anomalies that may be identified in early pregnancy e.g. anencephaly."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 1,
                "prefix": 6.2,
                "text": "First trimester combined test"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "The combined test uses maternal age, the nuchal translucency measurement (NT) and two biochemical tests, free beta hCG and PAPP-A, together with the gestational age calculated from crown rump length (CRL) measurement, to calculate the chance of the pregnancy being affected by T21 or T18/T13. The optimal time to perform the combined test is between  weeks 2 days to  weeks 1 day of gestation, which corresponds to a CRL of 45.0mm to 84.0mm"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Aims"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "prefix": 20.0,
                "text": "To offer screening and diagnosis to all women who attend for antenatal care before  weeks of pregnancy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "To provide up to date high quality information on the screening process to support women to make an informed decision whether to accept or decline the offer of screening."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "First trimester combined screening will be offered to all women who present for ultrasound scan between 11 weeks + 2 days to  weeks + 1 day (11+2 to14 +1)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "Second trimester serum screening will be offered to women who present at ultrasound scan between 14 weeks + 2 days and 20 weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "prefix": 7.5,
                "text": "Provide information and support to enable women and their partners to make a decision on the outcome of their pregnancy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "prefix": 7.6,
                "text": "For women with a confirmed diagnosis as a result of screening, who choose to continue with the pregnancy, provide optimal management for pregnancy, birth and the newborn period."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "prefix": 7.7,
                "text": "For women with a confirmed diagnosis as a result of screening, who opt for termination of pregnancy to ensure we provide optimal care and support, including bereavement support."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Objectives"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "To identify and offer screening to all women, who attend for care under 20 weeks of pregnancy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "All pregnant women should be provided with information \u2018Screening tests for you and your baby' prior to their booking appointment. This is available in English and  other languages, via www.gov.uk/government/publications/screening-tests-for-you-and-your- baby-description-in-brief."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "For women who do not have English as a first language, they must be offered interpreting services to help them make an informed choice about screening. It is not acceptable to use friends or family to translate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "To process and report on the screening tests in a timely manner"
            }
        },
        {
            "type": "table",
            "sequence_num": 58,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Screening standards"
                    },
                    {
                        "text": "Definition"
                    },
                    {
                        "text": "Evidence in guideline of standard"
                    },
                    {
                        "text": "7"
                    },
                    {
                        "text": "Standard 7: time to intervention (T21/T18/T13 screening) Timely communication of higher chance results"
                    },
                    {
                        "text": "See section 14.0"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "To offer appropriate tests and methods of screening that meet national standards. At Broomfield screening is primarily offered in the first trimester using the combined nuchal fold translucency (NT) and biochemical serum screening. A cut off of 1 in 150 for st Trimester Screening and 1 in 150 for 2nd Trimester Screening will be used to determine high and low chance results."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "To offer diagnostic tests to all women with screen positive results."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "To provide information and support for women with a confirmed diagnosis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "prefix": 8.7,
                "text": "To provide multidisciplinary education and training to all professionals involved in antenatal screening."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "prefix": 8.8,
                "text": "To have in place systems for risk assessment and management of adverse incidents occurring during the screening process."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Informed consent for Downs, Edwards and Pataus Screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "All women will be given verbal information regarding screening available to them at the point of accessing care, this should include a discussion on the screening process and time frame"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "All women should be informed of the screening available for Down's, Edward's and Patau's syndrome as early as possible in pregnancy, with at least 24 hours before they are asked to make any decisions."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "All women should be offered:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "text": "No screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "text": "Screening for T21 and T18 / T13"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "text": "Screening for T21 only"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "text": "Screening for T18 / T13 only."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "A specimen form (Appendix A) should be completed for the women ideally at the booking appointment. All pregnant women should be provided with information \u2018Screening tests for you and your baby' prior to their booking appointment. This is available in English and  other languages, via www.gov.uk/government/publications/screening-tests-for- you-and-your-baby-description-in-brief."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "prefix": 9.5,
                "text": "For women who do not have English as a first language, they must be offered interpreting services to help them make an informed choice about screening. It is not acceptable to use friends or family to translate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "prefix": 9.6,
                "text": "Where English is not the patient's first language an appropriate interpreter should be used to enable the woman to understand the information the information that she has been given."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "prefix": 9.7,
                "text": "The offer of screening and the decision to accept or decline should be recorded in the women handheld records maternity notes and on the maternity computer system. All women who decline Down's, Edward's and Patau's syndrome screening will be offered a scan to the date pregnancy and check for viability dating and detailed anomaly scan at 18 - 20+6 weeks of pregnancy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Down's, Edward's and Patau's screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "All women will be offered a dating scan and a screening test for Down's, Edward's and Patau's syndrome. The preferred screening test for Downs screening will be st trimester combined screening, this is offered between 11weeks and 2 days and  weeks and 1 day gestation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Women who have been found to have miscarried the pregnancy will be supported and referred to the Early Pregnancy Unit (EPU) for on-going management."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "Women access antenatal care later than14 weeks and 1day gestation can be offered a 2nd trimester serum \u2013 screening, between  week and 2 days - 20 weeks gestation. ( Refer to appendix B)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 1,
                "prefix": 10.4,
                "text": "Public Health England recommend that women should opt for one Downs, Edwards and Pataus Screening test. If women have a Downs screening result from an external non- invasive prenatal test (NIPT \u2013 also known as Harmony Screening) then combined screening should not be offered. Potential confusion can occur if the results are inconsistent in terms of the chance result."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "First trimester combined screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 1,
                "prefix": 11.1,
                "text": "First trimester combined test"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "The combined test uses maternal age, the nuchal translucency measurement (NT) and two biochemical tests, free beta hCG and PAPP-A, together with the gestational age calculated from crown rump length (CRL) measurement, to calculate the chance of the pregnancy being affected by T21 or T18/T13. The optimal time to perform the combined test is between  weeks and 2 days to  weeks and 1 day of gestation, which corresponds to a CRL of 45.0mm to 84.0mm"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "In cases where screening is accepted but it is not possible to obtain the NT measurement at the first appointment, a least one other attempt should be offered, this may be on the same day or at a later date. If it is not possible to obtain and accurate NT measurement despite \u2018twice on the couch' then further attempts do not have to be offered and the woman should be referred in to the second trimester screening pathway"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "If the ultrasound measurement shows that the CRL is less than 45.0mm, the woman should be recalled for a further scan to measure the NT. If the CRL is greater than 84.0mm, then second trimester quadruple test should be offered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "prefix": 11.4,
                "text": "A maternal blood specimen should be taken after the ultrasound scan and the combined test results made available within a few days of the biochemistry results being authorised by the laboratory."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "prefix": 11.5,
                "text": "When calculating a chance for T21 and /or T18/T13 syndromes, the nuchal translucency measurement must be used in combination with a maternal serum screening test."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 1,
                "text": "The nuchal translucency measurement must not be used in isolation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "prefix": 11.6,
                "text": "Where women have chosen not to accept screening for Down's, Edwards' and Patau's syndromes, but choose to accept an early pregnancy scan, structural anomalies may still be identified, including an NT of \u2265 3.5mm. Women should be aware that any such anomaly will be reported to enable appropriate offer of additional screening."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Second trimester screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "prefix": 16.0,
                "text": "The quadruple test uses maternal age and four biochemical markers measured from  weeks 2 days until  weeks 0 days \u2013 AFP, hCG (total, intact or free beta subunit), uE3 and inhibin-A. Although this combination of markers has a lower detection and standardised screen positive rate than the combined test, it is the nationally recommended screening strategy in the second trimester. The optimum time for testing in the second trimester is around  week's gestational age."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "There will always be a need for a screening test in the second trimester for those women who book too late for first trimester testing or when an NT measurement cannot be obtained (despite twice on the couch) in the first trimester. An ultrasound scan will be required to date the pregnancy and a fetal head circumference is the recommenced measurement used for women presenting in the second trimester."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 1,
                "prefix": 12.3,
                "text": "Twins / Multiple Fetus Detected on Scan"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Women with twin pregnancies are eligible for st and 2nd trimester screening."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "When ultrasound shows that there is an empty second sac, the biochemical markers appear no different to those in a singleton pregnancy and the combined test can be used to calculate the risk. If ultrasound shows that there is a second sac containing a fetus with no fetal heart pulsations (\u2018VanishedTwin') it is possible that there could be a contribution to the maternal biochemical markers for many weeks. The risk must be calculated by the laboratory. Therefore, blood forms should be completed as \u2018Vanished Twin for age and NT risk only'."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "st and 2nd Trimester screening cannot be used for any multiple pregnancies greater than two, please refer patient to the Screening Team for further"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "text": "management."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Results"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "The results of first and second trimester screening are entered into a software programme which calculates the chance for a woman of having a baby with Downs, Edwards or Pataus syndrome."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Low chance results"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Defined as having a less than1 in 150 chance for st Trimester Screening and 1 in 150 chance for 2nd Trimester Screening chance of having a baby with Downs Syndrome."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "All low chance results are emailed to the Antenatal Screening Team for failsafe purpose. A standard letter is sent to the women by the laboratory team to inform her that she has a low chance result, which should be receive within 10 days after the blood test."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "prefix": 14.3,
                "text": "The community midwife will discuss these results with the woman at her 16-18 week antenatal check."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "High chance results"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "High chance results are defined as results greater than than1 in 150 chance for st Trimester Screening and 1 in 150 chance for 2nd Trimester Screening for Down's, Edward's and Patau's."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "All high chance results are emailed to the Antenatal Screening team via the generic email address \u2013 antenataland.newbornscreening@nhs.net ."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "prefix": 15.3,
                "text": "Women with increased chanced results will be notified of the results within 3 working days of the Screening office receiving the results. The Antenatal Screening team will contact the woman to discuss the result, either by phone or in the Antenatal Clinic. Names and contact telephone numbers will be given for advice and support i.e. The Downs Syndrome Association, Langdon Down Centre, 2A, Langdon Park, Teddington, TW11 9PS Tel: 0845 230 0372  www.downs-syndrome.org.uk or the Support"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 1,
                "text": "Organisation for Trisomy 13/18 (SOFT) Tel: 0121 351 3122 | email: enquiries@soft.org.uk     http://soft.org.uk/"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "prefix": 15.4,
                "text": "Discussion with women will take place, with the following options offered:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "text": "No further testing"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "text": "CVS or amniocentesis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "text": "NHS NIPT Screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "text": "Detailed anatomy scan with fetal medicine."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "prefix": 15.5,
                "text": "If the patient wishes to have CVS or amniocentesis, she will be given verbal and written information to enable them to decide whether to have the procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 0,
                "prefix": 11.0,
                "text": "Chorionic Villus Sampling (CVS) is an abdominal invasive procedure performed under continuous ultrasound guidance. The CVS can be performed from  weeks of pregnancy to obtain a sample of placental tissue for chromosomal or genetic analysis. For every 100 women who have this test one will miscarry."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "prefix": 0.0,
                "text": "Amniocentesis is an invasive procedure undertaken from about 15 completed weeks (15) onwards to obtain a sample of amniotic fluid surrounding the fetus. Using an aseptic technique whilst under continuous ultrasound guidance, a sterile needle is passed through the mother's abdomen, uterus and amniotic sac. A sample of amniotic fluid is aspirated and sent for chromosomal or genetic analysis. For every 100 women who have this test one will miscarry."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "prefix": 15.8,
                "text": "In twin pregnancies invasive prenatal diagnosis can be offered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "prefix": 15.9,
                "text": "CVS procedures are undertaken at tertiary units, University College Hospital, London, Kings College Hospital, London. Any appointments at a tertiary unit will be arranged by the Antenatal Screening Team. Maps for the appropriate hospital are available from the antenatal screening team office. (Refer to the guideline entitled \u2018Guideline for Interpreting and Acting on CVS sample and Amniocentesis Results'; register number 08046)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "To action normal and abnormal results please refer to the guideline for interpreting and acting on chorionic villus sample (CVS) and amniocentesis results; register number 08046."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "prefix": 15.11,
                "text": "If the woman wishes to continue the pregnancy with no further testing, the Antenatal Screening team will formulate a plan of care; with a referral to the Tertiary Unit for a cardiac scan, (if the nuchal translucency measures 3.5 mm or above)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "prefix": 15.12,
                "text": "Following the cardiac scan results and subsequent discussion with the Antenatal Screening Team, the patient may wish to continue with the pregnancy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "prefix": 15.13,
                "text": "A neonatal alert form will be completed. A copy of the alert form is retained for the screening office records and a copy is forwarded to the named paediatric consultant for a plan of care post-delivery. (Refer to the \u2018Guideline for calling paediatric staff and for obtaining paediatric referral'; register number 09113) (Refer to Appendix B)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "prefix": 15.14,
                "text": "When the named Paediatric Consultant has completed the neonatal alert form with a care plan, a copy will be retained in the neonatal folder. A further copy will be sent to the Antenatal Screening team; who will then provide a subsequent copy for the Labour Ward folder. The Antenatal Screening team will provide a copy which should be filed in the patient's lilac folder."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Failsafe checks"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "The Screening failsafe officer receives a copy of all scans performed:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 0,
                "text": "Checks and identifies all women who have consented to screening,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "text": "Checks with biochemistry laboratory that all samples have been received in the laboratory for screening to be performed, this is done within 24 hours of screening."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 0,
                "text": "Any samples not received, women will be contacted and asked to be re-bled."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 0,
                "text": "Biochemistry laboratory will forward all results to the screening team for failsafe purposes and will collate with scan reports."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "text": "Chase via laboratory any samples that are not received"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 0,
                "text": "Results entered onto the cohort tracking database to ensure all women have results"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 0,
                "text": "for screening requested."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Reporting incidents within the screening programme"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "Any incidents related to the screening pathway / programme need to be reported via the Trust's incident reporting system, the Screening Coordinator / Deputy will review the Datix and if the incident meets the Antenatal and Newborn Screening Incident Criteria then an alert is sent by the Screening Team or Governance team to Public Health England (See Women's and Children's Division Clinical Governance Structure Policy 05098, 2019, Appendix B)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Record keeping"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "In terms of record keeping, it is essential to confirm the patient's name and date of birth before giving out information."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 0,
                "prefix": 18.2,
                "text": "If you are in a hospital setting, ensure that the hospital notes are available."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 0,
                "prefix": 18.3,
                "text": "All conversations, plans of care and decisions must be documented in the patient's health care"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 0,
                "text": "records."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Training requirements /guideline management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "As an integral part of the knowledge, skills framework, staff are appraised annually to ensure competency in computer skills and the ability to access the current approved guidelines via the Trust's intranet site"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 0,
                "prefix": 19.2,
                "text": "All midwifery and obstetric staff must attend yearly mandatory training, which includes skills and drills training, involving an antenatal screening update."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "prefix": 19.3,
                "text": "All midwifery and obstetric staff are to ensure that their knowledge and skills are up- to-date in order to complete their portfolio for appraisal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 0,
                "prefix": 19.4,
                "text": "As an integral part of the knowledge, skills framework, staff are appraised annually to ensure competency in computer skills and the ability to access the current approved guidelines via the Trust's intranet site"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Infection prevention"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 0,
                "prefix": 20.1,
                "text": "All staff should follow Trust guidelines on infection prevention by ensuring that they effectively \u2018decontaminate their hands' before and after each procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 0,
                "prefix": 20.2,
                "text": "All staff should ensure that they follow Trust guidelines on infection control, using Aseptic Non-Touch Technique (ANTT) when carrying out procedures i.e. obtaining blood samples."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Audit and monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "Audit of compliance with this guideline will be considered on an annual audit basis in accordance with the Clinical Audit Strategy and Policy (register number 08076), the Corporate Clinical Audit and Quality Improvement Project Plan and the Maternity annual audit work plan; to encompass national and local audit and clinical governance identifying key harm themes. The Women's and Children's Clinical Audit Group will identify a lead for the audit."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 0,
                "prefix": 21.2,
                "text": "As a minimum the following specific requirements will be monitored:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "text": "Designated lead for antenatal screening in the maternity service"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "text": "Antenatal screening tests, which follow the UK National Screening Committee guidance"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 0,
                "text": "System for ensuring that appropriate tests are undertaken within appropriate timescales"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 0,
                "text": "System for ensuring that appropriate tests are undertaken when patients book late"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 0,
                "text": "Process for the review of the results"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "Process for reporting all results to patients"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 0,
                "text": "Process for reporting results to other relevant healthcare professionals"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 0,
                "text": "Process for ensuring that patients with screen positive test results are referred and managed within appropriate timescales"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 0,
                "text": "Maternity service's expectations for staff training, as identified in the training needs analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 0,
                "text": "Process for audit, multidisciplinary review of results and subsequent monitoring of action plans"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 0,
                "prefix": 21.3,
                "text": "A review of a suitable sample will be audited from the health care records of patients who have delivered to evidence the process for ensuring that patients with screen positive test results are referred and managed within appropriate timescales. A minimum compliance 75% is required for each requirement. Where concerns are identified more frequent audit will be undertaken."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 0,
                "prefix": 21.4,
                "text": "The findings of the audit will be reported to and approved by the Multi-Disciplinary Risk Management Group (MRMG) and an action plan with named leads and timescales will be developed to address any identified deficiencies. Performance against the action plan will be monitored by this group at subsequent meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 0,
                "prefix": 21.5,
                "text": "The audit report will be reported to the monthly Directorate Governance"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 164,
            "data": {
                "is_heading": 0,
                "text": "Meeting (DGM) and significant concerns relating to compliance will be entered on the local Risk Assurance Framework."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 165,
            "data": {
                "is_heading": 0,
                "prefix": 21.6,
                "text": "Key findings and learning points from the audit will be submitted to the Clinical Governance Group within the integrated learning report."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 0,
                "prefix": 21.7,
                "text": "Key findings and learning points will be disseminated to relevant staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Approval and implementation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "All policies, procedures and guidelines will be approved by the MSE Maternity and Gynaecology Policy Working Group which is the specialist group with the authority to approve local policies and guidelines. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 169,
            "data": {
                "is_heading": 0,
                "prefix": 22.2,
                "text": "It is the author's responsibility to inform the relevant staff of the approved policy documents when they are uploaded to the Trust's Intranets."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 170,
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Equality impact assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 0,
                "prefix": 23.1,
                "text": "Mid and South Essex NHS Foundation Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals. (Refer to Appendix 1)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 172,
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 173,
            "data": {
                "is_heading": 0,
                "text": "Fetal Anomaly Screening Programme - Screening for Downs Syndrome: UK NSC Policy recommendations 2011\u20132014 Model of Best Practice"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 0,
                "text": "Fetal Anomaly Screening Programme: Programme Handbook (2015)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 175,
            "data": {
                "is_heading": 0,
                "text": "Antenatal Screening Service for Downs Syndrome in England (2007) Antenatal Screening \u2013 Working Standards for Downs Syndrome Screening 2007."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 176,
            "data": {
                "is_heading": 0,
                "text": "\u201cScreening Tests for You and Your Baby\u201d UK National Screening Committee (2017)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 177,
            "data": {
                "is_heading": 0,
                "text": "NHS Public Health Functions Agreement 2015-16 (2014) Service Specification No.16. NHS Fetal Anomaly Screening Programme. Screening for Down's, Edward's and Patau's Syndromes (Trisomy 21, 18, 13)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 178,
            "data": {
                "is_heading": 1,
                "text": "Appendix A: Down's Edwards and Patau's Syndrome screening"
            }
        },
        {
            "type": "image",
            "sequence_num": 179,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.003.png"
            }
        },
        {
            "type": "image",
            "sequence_num": 180,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.004.jpeg"
            }
        },
        {
            "type": "image",
            "sequence_num": 181,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.003.png"
            }
        },
        {
            "type": "image",
            "sequence_num": 182,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.005.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 183,
            "data": {
                "is_heading": 1,
                "text": "Appendix B: Neonatal alert form"
            }
        },
        {
            "type": "image",
            "sequence_num": 184,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.003.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 185,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Neonatal Alert Form"
                    },
                    {
                        "text": "First Name"
                    },
                    {
                        "text": "Surname"
                    },
                    {
                        "text": "NHS No"
                    },
                    {
                        "text": "Hospital No"
                    },
                    {
                        "text": "Referral Date"
                    },
                    {
                        "text": "EDD"
                    },
                    {
                        "text": "Gestation"
                    },
                    {
                        "text": "Consultant"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 186,
            "data": {
                "is_heading": 1,
                "text": "Background history & problem summary"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 187,
            "data": {
                "is_heading": 1,
                "text": "Delivery Plans"
            }
        },
        {
            "type": "image",
            "sequence_num": 188,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.006.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 189,
            "data": {
                "is_heading": 0,
                "text": "Broomfield Hospital  Not Decided"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 190,
            "data": {
                "is_heading": 0,
                "text": "Other Hospital   _____________________________________"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 191,
            "data": {
                "is_heading": 1,
                "text": "Neonatal Alert Form Criteria"
            }
        },
        {
            "type": "image",
            "sequence_num": 192,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.007.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 193,
            "data": {
                "is_heading": 0,
                "text": "Please use the neonatal alert form for the following conditions:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 194,
            "data": {
                "is_heading": 0,
                "text": "Multiple pregnancy (higher order > 2 fetus)  \uf0b7  Severe oligohydramnios / IUGR"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 195,
            "data": {
                "is_heading": 0,
                "text": "Hepatitis B positive mother  \uf0b7  Abnormal dopplers"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 196,
            "data": {
                "is_heading": 0,
                "text": "HIV positive mother  \uf0b7  Genetic / hereditary conditions in the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 197,
            "data": {
                "is_heading": 0,
                "text": "Previous baby with GBBS sepsis / meningitis  immediate family that may affect the fetus"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 198,
            "data": {
                "is_heading": 0,
                "text": "Significant structural abnormalities  \uf0b7  Social e.g. drug abuse, alcohol abuse in this diagnosedon ultrasound scan  pregnancy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 199,
            "data": {
                "is_heading": 0,
                "text": "All cases that require referral to specialist  \uf0b7  Any other condition that will require paediatric units for treatment or advice  input at birth"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 200,
            "data": {
                "is_heading": 0,
                "text": "Mothers with high antibody titres e.g. Anti-D, C and Kell"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 201,
            "data": {
                "is_heading": 1,
                "text": "Postnatal Plan (paediatric)"
            }
        },
        {
            "type": "image",
            "sequence_num": 202,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.008.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 203,
            "data": {
                "is_heading": 0,
                "text": "Designation   _________________________  Date _________________________  Print Name   _________________________  Signature _________________________"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 204,
            "data": {
                "is_heading": 1,
                "text": "Appendix C: Antenatal and newborn screening 1st trimester screening standard operating procedure"
            }
        },
        {
            "type": "image",
            "sequence_num": 205,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.009.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 206,
            "data": {
                "is_heading": 0,
                "text": "Women refer for Antenatal Care"
            }
        },
        {
            "type": "image",
            "sequence_num": 207,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.010.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 208,
            "data": {
                "is_heading": 0,
                "text": "Referral processed and initial booking appointment arranged to see Midwife \u2013 letter sent to women with information regarding their booking appointment, scan date"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 209,
            "data": {
                "is_heading": 0,
                "text": "Antenatal Booking Performed ideally before 10 weeks, screening discussed and screening offered for HIV, Hepatitis B, Syphilis, Haemoglobinopathy Screening, Combined Screening, Anomaly Scan, FBC, Blood Group and MSU. Plan of care discussed for the pregnancy after all assessments are completed including assessment of medical conditions, family history of health concerns that may affect the baby, plan of care for"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 210,
            "data": {
                "is_heading": 1,
                "text": "the pregnancy discussed including screening pathways, Screening tests for you and your baby booklet given Bloods for screening to be taken at booking or within 5 days"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 211,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Declined  st Trimester Screening (scan) performed between 11+2 and 14 Combined  weeks"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 212,
            "data": {
                "is_heading": 0,
                "text": "Screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 213,
            "data": {
                "is_heading": 0,
                "text": "Combined screening bloods taken directly following scan in antenatal Routine  clinic"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 214,
            "data": {
                "is_heading": 0,
                "text": "care"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 215,
            "data": {
                "is_heading": 0,
                "text": "Bloods taken to the screening Office for Failsafe Check of form and sample before sending to the laboratory for screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 216,
            "data": {
                "is_heading": 0,
                "text": "Sample sent to the laboratory"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 217,
            "data": {
                "is_heading": 0,
                "text": "Laboratory to perform screening and issue a result within three working days"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 218,
            "data": {
                "is_heading": 0,
                "text": "Increased chance results emailed to Low chance results emailed to screening teams generic email"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 219,
            "data": {
                "is_heading": 0,
                "text": "address \u2013 antenataland.newbornscreening@nhs.uk along with  screening teams generic email address \u2013 antenataland.newbornscreening@nhs.uk"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 220,
            "data": {
                "is_heading": 0,
                "text": "failsafe list of samples processed"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 221,
            "data": {
                "is_heading": 0,
                "text": "Receipt email sent back to laboratory to Low chance results / Declined screening married up with scan"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 222,
            "data": {
                "is_heading": 0,
                "text": "acknowledge receiving result reports and entered onto cohort tracker"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 223,
            "data": {
                "is_heading": 0,
                "text": "Woman contacted regarding Increased chance result within 24 hours of the result being received in screening office"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 224,
            "data": {
                "is_heading": 0,
                "text": "Result either discussed over the phone or face to face (woman's preference), discuss results and what the chance result means, how we got to the results for the individual pregnancy, what options are available in pregnancy for further screening / testing \u2013"
            }
        },
        {
            "type": "image",
            "sequence_num": 225,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.011.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 226,
            "data": {
                "is_heading": 0,
                "text": "No further action"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 227,
            "data": {
                "is_heading": 0,
                "text": "CVS / Amniocentesis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 228,
            "data": {
                "is_heading": 0,
                "text": "Soft Marker Scans"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 229,
            "data": {
                "is_heading": 0,
                "text": "NIPT (Non Invasive Prenatal Testing)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 230,
            "data": {
                "is_heading": 0,
                "text": "Arrange any follow up care for the woman, give screening contact numbers and offer support."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 231,
            "data": {
                "is_heading": 0,
                "text": "If NIPT, CVS / Amniocentesis or Soft marker scan ensure Screening team follow up results"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 232,
            "data": {
                "is_heading": 0,
                "text": "NIPT result  CVS arranged  Amniocentesis  Soft marker scan and performed  arranged and  performed"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 233,
            "data": {
                "is_heading": 0,
                "text": "performed"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 234,
            "data": {
                "is_heading": 0,
                "text": "Lo w Probability  High"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 235,
            "data": {
                "is_heading": 0,
                "text": "Probability"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 236,
            "data": {
                "is_heading": 0,
                "text": "No further action  Negative  Anomalies"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 237,
            "data": {
                "is_heading": 0,
                "text": "result  seen"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 238,
            "data": {
                "is_heading": 0,
                "text": "No further action  Counsel  Negative result  Positive result  Referral to regarding  for  Fetal"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 239,
            "data": {
                "is_heading": 0,
                "text": "invasive testing  Chromosomal  Medicine anomaly  Unit"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 240,
            "data": {
                "is_heading": 0,
                "text": "Continue with  Termination of pregnancy  pregnancy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 241,
            "data": {
                "is_heading": 0,
                "text": "Woman contacted regarding Increased chance result within 24 hours of the result being received in screening office"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 242,
            "data": {
                "is_heading": 0,
                "text": "Antenatal screening for Down's Edwards and Patau's syndrome / 08058 / 5.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 243,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "image",
            "sequence_num": 244,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.012.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 245,
            "data": {
                "is_heading": 1,
                "text": "Appendix4: Preliminary equality analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 246,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Antenatal screening for Down's Edwards and Patau's syndrome/08058 (Please tick all that apply)"
            }
        },
        {
            "type": "table",
            "sequence_num": 247,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2612 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2610 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 248,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Full review"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "3 yearly review"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients and staff"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Please refer to pages 1 and 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 249,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Emma Neate"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Specialist Midwife for Antenatal and Newborn Screening"
                    },
                    {
                        "text": "10 September 2021"
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 250,
            "data": {
                "url": "08058 Antenatal screening for Downs Edwards and Pataus syndrome 5.0.002.png"
            }
        }
    ]
}